Dergiler / Medeniyet Medical Journal / 2016 / Cilt: 31 - Sayı: 4

Utility of diffusion-weighted magnetic resonance imaging in diagnosing hepatocellular carcinoma in cirrhotic liver

Diffüzyon ağırlıklı magnetik rezonans görüntülemenin, sirotik karaciğerde hepatosellüler kanser tanısında yararı

Sayfa
266–273
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

DWI alone has a limited capability to detect HCC, but it can be used for imaging cirrhotic liver to supply ancillary findings in addition to dynamic contrast-enhanced MRI in diagnosing HCC.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:We aimed to introduce the utility of diffusion-weighted images (DWI) in differentiating hepatocellular carcinoma (HCC) from dysplastic nodules (DN) in cirrhotic liver.
📊
Temel Bulgular & Veri:Statistical significance was set at p<0.05.
💡
Sonuç & Katkı:DWI alone has a limited capability to detect HCC, but it can be used for imaging cirrhotic liver to supply ancillary findings in addition to dynamic contrast-enhanced MRI in diagnosing HCC.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

We aimed to introduce the utility of diffusion-weighted images (DWI) in differentiating hepatocellular carcinoma (HCC) from dysplastic nodules (DN) in cirrhotic liver. DWI studies of the patients who had cirrhosis and HCC or cirrhosis and DN were evaluated retrospectively. Signal intensities of the lesions were classified as hyper-, iso- or hypointense on DWI. Apparent diffusion coefficient (ADC) and ADC ratios (the ratio between lesion ADC, and ADC of the surrounding liver parenchyma) was obtained, and mean values were compared. Statistical significance was set at p<0.05. Ninety-five lesions were diagnosed with HCC and forty-four lesions with DN from a total of 87 patients. The hyperintensity on DWI, mean ADC, and ADC ratio of HCCs were statistically significant (p<0.001 for all parameters). An ADC value of ≤ 1.316x10-3 mm²/s and an ADC ratio of ≤ 0.94 obtained by ROC curve analysis, were found to be the best cut-off values. DWI alone has a limited capability to detect HCC, but it can be used for imaging cirrhotic liver to supply ancillary findings in addition to dynamic contrast-enhanced MRI in diagnosing HCC.

Abstract

Bu çalışmada, sirotik karaciğerde hepatosellüler kanseri (HSK), displastik nodüllerden (DN) ayırımında diffüzyon ağırlıklı görüntülerin (DAG) yararını ortaya koymayı amaçladık. Siroz ve hepatosellüler kanser veya siroz ve displastik nodülü olan hastaların DAG’ları geriye dönük olarak değerlendirildi. DAG’da lezyonların sinyal intensiteleri hiper, izo veya hipointens olarak sınıflandırıldı. Apparent diffusion coefficient (ADC) ve ADC oranları (lezyon ADC’sinin lezyonu çevreleyen karaciğer parankimi ADC’sine oranı) karşılaştırıldı. İstatistiksel anlamlılık p<0,05 olarak kabul edildi. Seksen yedi hastadan, 95 HSK tanılı lezyon ve 44 DN tanılı lezyon elde edildi. DAG’da hiperintensite, ortalama ADC ve ADC oranı istatistiksel olarak anlamlı bulundu (p<0,001 tüm parametreler için). ROC analizi ile ADC değeri olarak 1.316x10-3 mm²/s veya altı ve ADC oranı olarak 0,94 veya altı, en iyi kestirim değeri olarak hesaplandı. DAG tek başına HSK tespit etmede kısıtlı kabiliyete sahiptir. Ancak dinamik kontrastlı MRG’ye ek olarak, sirotik karaciğerde HSK tanısında yardımcı bulgular sağlayabilmek için kullanılabilir.

🔖

Bu Makaleye Atıf Yap

ASLAN, A., İNAN, İ., KARAGÖZ, V., ASLAN, M., ACAR, M. (2016). Utility of diffusion-weighted magnetic resonance imaging in diagnosing hepatocellular carcinoma in cirrhotic liver. Medeniyet Medical Journal, Cilt: 31 - Sayı: 4, 266–273. https://ajindex.com/articles/283370

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Parente DB, Perez RM, Eiras-Araujo A, et al. MR imaging of hypervascular lesions in the cirrhotic liver: a diagnostic dilemma. Radiographics 2012;32:767-787.
  2. Bruix J, Sherman M. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: An update. J Hepatol 2011;53:1020-1022.
  3. Piana G, Trinquart L, Meskine N, et al. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases. J Hepatol 2011;55:126-132.
  4. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL–E ORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol 2012;56:908-943.
  5. AJR LIRADS v2013.1 Available at: http://www.acr.org/qualitysafety/resources/LIRADS. Last accessed: May 1, 2015
  6. Lim KS. Diffusion-weighted MRI of hepatocellular carcinoma in cirrhosis. Clin Radiol 2014;69:1-10.
  7. Guo L, Liang C, Yu T, et al. 3 T MRI of hepatocellular carcinomas in patients with cirrhosis: does T2-weighted imaging provide added value? Clin Radiol 2012;67:319-328.
  8. Galea N, Cantisani V, Taouli B. Liver lesion detection and characterization: role of diffusion-weighted imaging. J Magn Reson Imaging 2013;37:1260-1276.
  9. Hussain SM, Reinhold C, Mitchell DG. Cirrhosis and lesion characterization at MR imaging. Radiographics 2009;29:1637- 1652.
  10. Watanabe A, Ramalho M, AlObaidy M, et al. Magnetic resonance imaging of the cirrhotic liver: An update. World J Hepatol 2015;27:468-487.
  11. Takayama T, Makuuchi M, Hirohashi S, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 1990;336:1150-1153.
  12. Vandecaveye V, De Keyzer F, Verslype C, et al. Diffusionweighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur Radiol 2009;19:2456-2466.
  13. Rimola J, Forner A, Tremosini S, et al. Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrh